EP 4028392 A1 20220720 - COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS
Title (en)
COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG DES RESPIRATORISCHEN SYNCYTIALVIRUS
Title (fr)
COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT DU VIRUS RESPIRATOIRE SYNCYTIAL
Publication
Application
Priority
- US 201962897964 P 20190909
- US 202062959772 P 20200110
- US 202062970506 P 20200205
- US 202062994203 P 20200324
- US 2020050022 W 20200909
Abstract (en)
[origin: WO2021050612A1] Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral RSV F protein (e.g., Presatovir, MDT 637, JNJ 179, TMC353121, Ziresovir, or an analog thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., RSV infections).
IPC 8 full level
C07D 401/14 (2006.01); A61K 31/438 (2006.01); A61K 31/503 (2006.01); A61K 38/38 (2006.01); C07D 401/06 (2006.01); C07D 471/04 (2006.01)
CPC (source: EP)
A61K 47/68 (2017.07); A61P 31/14 (2017.12); C07D 417/14 (2013.01); C07D 471/20 (2013.01); C07D 487/04 (2013.01)
Citation (search report)
See references of WO 2021050612A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2021050612 A1 20210318; AU 2020345850 A1 20220428; CA 3153626 A1 20210318; CN 114728937 A 20220708; EP 4028392 A1 20220720; JP 2022547538 A 20221114; MX 2022002842 A 20220614
DOCDB simple family (application)
US 2020050022 W 20200909; AU 2020345850 A 20200909; CA 3153626 A 20200909; CN 202080077245 A 20200909; EP 20863252 A 20200909; JP 2022515651 A 20200909; MX 2022002842 A 20200909